Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15010 total
Prime Medicine enters the week in an unusual spot for a heavily shorted biotech — the stock is up 8% on the week and 30% over the past month, while bears have been quietly adding to already elevated positions. The…
Noble Corporation heads into its July 24 Q2 results with analysts trimming targets, short interest grinding higher, and the stock already down 15% over the past month — a setup where the earnings print carries more…
QuidelOrtho shed 5.6% on Tuesday to close at $17.00, pulling back from the rally highs even as Citigroup raised its price target the same morning — a split signal that captures the stock's awkward positioning ahead of…
Warner Bros. Discovery has slipped 2% on the week to $26.12, and with Q1 results now confirmed for August 7, the focus shifts to what the next print will reveal about the streaming-versus-linear trade-off. The most…
HF Sinclair enters its July 28 Q2 earnings report with the stock up 6% on the week but options traders notably more defensive than their recent baseline — a split signal that defines the setup heading into the…
CHYM heads into the week with an unusual split: shorts have quietly added exposure over the past month, yet the Street just opened with a fresh bullish initiation from a major bank. Barclays kicked off coverage this…
ProFrac Holding Corp. has spent the past week in freefall, yet its options market is sending an unusually bullish signal — creating one of the more counterintuitive setups in the oilfield services space right now. The…
Hagerty, Inc. heads into the week with a rare tailwind: a same-day analyst upgrade and a stock that has gained 16% in a month, now trading at $12.15 and closing in on the consensus price target. The most notable…
TSAT enters the week of July 8 with a sharp sell-off, heavy short positioning, and a borrow market that remains wide open — a combination that tells the story of bears in control but with no mechanical squeeze pressure…
Navitas Semiconductor heads into its July 27 earnings with a brutal month behind it and a cluster of insider selling that, in hindsight, marked the peak almost perfectly. The stock closed at $13.99 on July 7, down 22%…
GLOBALFOUNDRIES heads into its July 28 earnings report with the stock in sharp retreat and options traders hedging at their most defensive level in months. The stock's 20% slide in a single week — closing at $65.84 on…
First Watch Restaurant Group heads into its August 4 earnings date with short sellers maintaining meaningful exposure while the Street remains uniformly bullish — a gap that defines the stock's current tension. Short…
Hippo Holdings heads into its July 30 earnings date with options positioning near its most bullish extreme of the past year, even as insiders have been quietly trimming throughout the quarter. The options signal is the…
Core & Main heads into the week as one of the cleaner stories in its sector right now — a stock down sharply from its highs, a Street that still sees meaningful upside, and a lending market with no pressure…
GXO Logistics heads into its August earnings window with a notable disconnect: the Street is turning more constructive, yet short positions have climbed nearly a quarter in a month. The analyst story is the most…
T1 Energy heads into earnings season with a stock in freefall, a major strategic shareholder cutting its position, and short sellers sitting on nearly a quarter of the free float. The week's defining move was brutal.…
RIVN enters its July 28 earnings window under genuine pressure, with Tuesday's 18% single-session collapse dragging the stock to $16.49 and reigniting a bear thesis that shorts have been steadily rebuilding all…
Ryan Specialty Holdings has gained 10% in a single week, and the Street scrambled to keep up — making this the most analyst-active week the stock has seen in months. The pace of target revisions tells the story…
DT Midstream enters the final stretch before its July 31 Q2 results with a fresh analyst endorsement and options traders showing unusually little demand for downside protection. JP Morgan's Jeremy Tonet raised his…
Vera Therapeutics enters the second week of July with a striking split: five analysts raised price targets on the same day the stock jumped 7%, yet short sellers are sitting on nearly 19% of the float with no sign of…
